Conference on Therapeutical Purposes Research and Development II. E

PROGRAM OVERVIEW


 

Conference on Therapeutical Purposes

Research and Development II.

 

 

 

Head of the Conference:

Prof. Dr. Zoltán Szilvássy


Secretary of Conference:

Prof. Dr. Ildikó Bácskay


Conference Scientific Committee:

Dr. Béla Juhász

Dr. Rita Kiss

Dr. Pálma Fehér

Dr. Zoltán Ujhelyi


 

 

 

 

23-24 Sept 2021

Debrecen online conference

Hungary

 

 

 

Welcome to the 2nd online Conference on Therapeutical Purposes Research and Development. Taking place on September 23-24, 2021 in Debrecen, Hungary. The Conference aims to summarize the results of the project called R&D for Therapeutical Purposes and gives opportunity for international partners to introduce their researches. Young scientists were also highlighted to present their work. We invite all participants to join our online conference where we can share the experiences and discuss our developments.

 

 

 


 

Planned SHORT TALKS

 

 

Chair: Prof. Dr. Ildikó Bácskay

 

 

Marc Le Borgne:

Strategies for the design of protein kinase CK2 inhibitors 

 

Christelle Marminon:

Synthesis of indenoindoles and their evaluation as bioactive molecules –

 

Zoltán Ujhelyi, Dóra Kósa, Ágota Pető, Miklós Vecsernyés:

Development of oral peptide delivery systems, a complicated puzzle of possibilities

 

Pálma Fehér, Liza Józsa, Ildikó Bácskay:

Formulation of self-emulsifying system containing curcumin for external dosage form.

 

Tamás Köbling, László Maroda, Zita Váradi, Melinda Nyisztor, Éva Katona, Dénes Páll, Miklós Zrínyi:

Predictors of dietary self-efficacy in high hba1c type 2 diabetic patients.

 

Zita Váradi, Tamás Köbling, László Maroda, Melinda Nyisztor, Éva Katona, Dénes Páll, Miklós Zrínyi:

Discriminating low to high hba1c type 2 diabetic patients using psychosocial determinants including therapeutic adherence measures.

 

László Maroda, Miklós Zrínyi, Tamás Köbling, Zita Váradi, Melinda Nyisztor, Éva Katona, Dénes Páll:

Difference in self- and physician reported type 2 diabetic patient adherence as a function of hba1c and psychometric measures.

 

Diana Gavra, Pálma Fehér, Liza Józsa, Annamária Pallag, Ildikó Bácskay Tünde Jurca:

Development and evaluation of topical formulation Containing Rosa damascena lyophilized extract

 

Jurca Tünde, Pallag Annamaria, Marian Eleonora, Vicas Laura, Muresan Mariana, Gavra Diana:

Phytochemical Screening, Antioxidant Activity And Extraction Of Active Compound From Different Medicinal Plant Species Growing In The Bihorhajdú Bihar Area

 

Pallag Annamaria, Jurca Tünde, Marian Eleonora, Vicas Laura, Muresan Mariana, Burlou Nagy Cristina:

Current Perspectives In The Study Of Medicinal Plant Species Growing In The Bihor- Hajdú Bihar Area

 

Csernoch László:

The role of astaxanthin in the evolution of multicellular organisms

 

Singlár Zoltán :

Carotenoids, as biological mediators responsible for enhanced skeletal muscle function

 

Sztretye Mónika,:

Assesing the potentials of nutraceuticals in mice

 

Claude Collet :

The deleterious effects of new insecticides on the neurophysiology and the behaviour of the honey bee

 

Barbara Takács1, Zita Wachal1, Anna Szilágyi1, Adrienn Mónika Szabó1, Dániel Priksz1, Mariann Bombicz1, Judit Szilvássy2, Béla Juhász1, Balázs Varga1, Zoltán Szilvássy1

Improved survival and retinal function of aging ZDF rats in long-term, uncontrolled diabetes by BGP-15 treatment

 

Anna Szilágyi1, Barbara Takács1, Réka Szekeres1, Béla Juhász1, Csaba Hegedűs1, Ede Frecska2, Attila Kovács2, Zoltán Szilvássy1, Balázs Varga1

The therapeutic properties of the main components of Ayahuasca in retinal ischaemia-reperfusion injury

 

Réka Szekeres1, Rita Kiss1, Dániel Priksz1, Mariann Bombicz1, Balázs Varga1, Anna Szilagyi1, Barbara Takács1, Judit Remenyik2, Georgina Pesti-Asbóth2, Rudolf Gesztelyi1, Tamás Erdei1, Gábor Viczjan1, Ignác Ovari1, Zoltan Szilvássy1, Béla Juhász1

Prunus Cerasus-Extract Improves Hypercholesterinaemia-Induced Cardial Dysfunction Is Aging Rabbit Model

 

Nóra Lampé1, Dániel Priksz1, Tamás Erdei1, Mariann Bombicz1, Rita Kiss1, Balázs Varga1, Judit Zsuga2, Tamás Szerafin3, Zoltán Csanádi3, György Balla4, József Balla5, Zoltán Szilvássy1, Rudolf Gesztelyi1, Béla Juhász1

Negative Inotropic Effect Of BGP-15 On The Human Right Atrial Myocardium

 

Ignac Ovari1, Gabor Viczjan1, Tamas Erdei1, Nora Lampe1, Judit Zsuga2, Zoltan Szilvassy1, Bela Juhasz1, Rudolf Gesztelyi1

An Interaction Between Effects Of FSCPX (A Verified Irreversible A1 Adenosine Receptor Antagonist And Putative Irreversible Adenosine-Related Enzyme Inhibitor) And NBTI (An Adenosine Transport Inhibitor) In Isolated, Paced Rat And Guinea Pig Left Atria

 

Gabor Viczjan1, Ignac Ovari1, Tamas Erdei1, Nora Lampe1, Judit Zsuga2, Zoltan Szilvassy1, Bela Juhasz1, Rudolf Gesztelyi1

Kinetic Aspects Of The Effect Of FSCPX, A Verified Irreversible A1 Adenosine Receptor Antagonist And Putative Irreversible Adenosine-Related Enzyme Inhibitor, Under Ex Vivo Experimental Conditions

 

Rita Kiss1, Andrea Badale1, Csaba Hegedűs1, Mariana Muresan2, Mariann Bombicz1, Balázs Varga1, Anna Szilágyi1, Dávid Sinka3, Ildikó Bácskay3, Mihaela Popoviciu4, Ioan Magyar2, Mária Magdolna Szarvas5, Erzsébet Szőllősi5, József Németh1, Zoltán Szilvássy1, Annamaria Pallag6

Equisetum Arvense L. (Horsetail) Modulates Insulin Sensitivity In Streptozotocin Induced Diabetic Rats

 

Dana Romanescu1, Mihaela Popoviciu1,Ioan Magyar2, Rita Kiss3,Anna Szilágyi3, Barbara Takács3, Réka Szekeres3, Sándor Somodi4, Péter Kovács4, Zoltán Szabó5, József Németh3, Zoltán Szilvássy3, Béla Juhász3

The Role Of Hegc (Hyperinsulinemic Euglycemic Glucose Clamp) In Prediabetes

 

Muresan Mariana1, Pallag Annamaria2, Jurca Tünde2, Micle Otilia1, Marian Eleonora2, Vicas Laura2, Clichici Simona3, Filip Adriana3

Evaluation Of Antimicrobial Activity And In Vitro Studies On Cell Cultures Of Different  Herbal Extracts  Harvested From The Bihor -Hajdú Bihar County Area

 

Block discussion

 

 


 

"The research was supported by the Thematic Excellence Programme (TKP2020-IKA-04) of the Ministry for Innovation and Technology in Hungary."

 

 

 

 

 

 

 

 

 

 

 

 

Last update: 2023. 01. 19. 14:43